The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
Recruiting
- Conditions
- Hematologic Diseases
- Registration Number
- NCT06222164
- Lead Sponsor
- Invivoscribe, Inc.
- Brief Summary
Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research
- Detailed Description
Residual specimen/sample collection study where peripheral blood (PB), bone marrow (BM), genomic (gDNA), and/or formalin-fixed paraffin-embedded tissue (FFPE) specimens/samples are obtained from patient samples sent to LabPMM, LLC for clinical testing. Samples may be used for Clinical Research at LabPMM, LLC or at partner institutions
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
- Specimen/sample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and/or formalin-fixed paraffin-embedded tissue (FFPE) from patients whose specimens/samples have been sent to LabPMM for clinical testing
- Donor Age ≥ 18 years
Exclusion Criteria
- Sample/specimen has been obtained from a third-party vendor with a Materials Transfer Agreement (MTA) on file with LabPMM
- The specimens/samples have previously been enrolled in a clinical study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Enrollment 3 years N=2000
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
LabPMM
🇺🇸San Diego, California, United States